8YK4 | pdb_00008yk4

Structure of SARS-CoV-2 RBD and antibody NT-108


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.20 Å
  • R-Value Free: 
    0.267 (Depositor), 0.272 (DCC) 
  • R-Value Work: 
    0.243 (Depositor), 0.245 (DCC) 
  • R-Value Observed: 
    0.244 (Depositor) 

Starting Model: in silico
View more details

wwPDB Validation   3D Report Full Report


This is version 1.0 of the entry. See complete history


Literature

Structural Basis for Potent Neutralization Activity of SARS-CoV-2 Antibody, NT-108

Anraku, Y.Tadokoro, T.Suzuki, T.Sasaki, J.Hashiguchi, T.Kita, S.Shiwa, N.Iwata, N.Nagata, N.Suzuki, T.Kazuki, Y.Fukuhara, H.Oshimura, M.Sato, A.Sasaki, M.Orba, Y.Sawa, H.Maenaka, K.

To be published.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
antibody NT-108, single chain Fv fragment282Homo sapiensMutation(s): 0 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 2
MoleculeChains Sequence LengthOrganismDetailsImage
Spike protein S1B [auth C]215Severe acute respiratory syndrome coronavirus 2Mutation(s): 0 
UniProt
Find proteins for A0A7U3DZD0 (Severe acute respiratory syndrome coronavirus 2)
Explore A0A7U3DZD0 
Go to UniProtKB:  A0A7U3DZD0
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupA0A7U3DZD0
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.20 Å
  • R-Value Free:  0.267 (Depositor), 0.272 (DCC) 
  • R-Value Work:  0.243 (Depositor), 0.245 (DCC) 
  • R-Value Observed: 0.244 (Depositor) 
Space Group: I 2 2 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 55.152α = 90
b = 149.641β = 90
c = 253.429γ = 90
Software Package:
Software NamePurpose
XDSdata reduction
Aimlessdata scaling
PHENIXrefinement

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Japan Agency for Medical Research and Development (AMED)JapanJP20fk0108298
Japan Agency for Medical Research and Development (AMED)JapanJP20ae0101047
Japan Agency for Medical Research and Development (AMED)JapanJP20am0101093

Revision History  (Full details and data files)

  • Version 1.0: 2025-03-12
    Type: Initial release